BIOMERICA INC Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount
BIOMERICA INC (BMRA) reported Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount of $3.00 thousand for the 12-month period ending 2025-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Notes › Income Taxes
us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount · last filed 2026-08-31
- BIOMERICA INC effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2025 was $3.00K.
- BIOMERICA INC effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2023 was -$5.00K, a 145.45% decline from fiscal 2022.
- BIOMERICA INC effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2022 was $11.00K, a 92.41% decline from fiscal 2021.
- BIOMERICA INC effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2021 was $145.00K, a 26.34% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 12 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 12 month as first filed |
|---|---|---|
| 2025-05-31 | $3.00K 10-K · filed 2026-08-31 | -$3.00K 10-K · filed 2025-08-29 |
| 2023-05-31 | -$5.00K 10-K · filed 2024-08-28 | |
| 2022-05-31 | $11.00K 10-K · filed 2023-08-25 | |
| 2021-05-31 | $145.00K 10-K · filed 2022-08-29 | $144.70K 10-K/A · filed 2021-10-14 |
| 2020-05-31 | $196.84K 10-K/A · filed 2021-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |